News Headlines Article

Study: Risk of death drops with Type 2 diabetes pill Jardiance
Modern Healthcare

Jardiance sharply reduced chances of dying in diabetic patients at high risk of heart complications, a study shows, making the medication the first to lengthen diabetics’ lives.

The daily pill for Type 2 diabetes reduced deaths from heart complications by 38%, deaths from any cause by 32% and hospitalizations due to chronic heart failure by 35%, according to the study by Jardiance makers Eli Lilly and Boehringer Ingelheim.